Takeda halts trial of orexin drug in narcolepsy on safety groundsJapanese drugmaker Takeda has suspended dosing in phase 2 trials of its orexin agonist TAK-994, saying it had Share XTakeda halts trial of orexin drug in narcolepsy on safety groundshttps://pharmaphorum.com/news/takeda-halts-trial-of-orexin-drug-in-narcolepsy-on-safety-grounds/
Harmony’s sleep disorder drug Wakix gets US label extensionHarmony Biosciences has scored an expanded use for its Wakix narcolepsy drug to include cataplexy – a symptom Share XHarmony’s sleep disorder drug Wakix gets US label extensionhttps://pharmaphorum.com/news/harmonys-narcolepsy-drug-gets-extended-cataplexy/
FDA approves Jazz Pharmaceuticals’ narcolepsy therapyThe FDA has approved Jazz Pharmaceuticals’ sleep disorder drug Xywav, to treat daytime sleepiness in patients with narcolepsy, Share XFDA approves Jazz Pharmaceuticals’ narcolepsy therapyhttps://pharmaphorum.com/news/fda-approves-jazz-pharmaceuticals-narcolepsy-therapy/
